Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.64 USD | +0.38% | -0.90% | -28.32% |
04-15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
02-26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Other languages